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Background: The repression of negative emotions is a personality factor that received considerable attention in the
1950-60s as being relevant to the onset and course of rheumatoid arthritis (RA). Despite subsequent, repeated
criticisms of the cross-sectional nature of the earlier studies, even to date few prospective studies have been
reported on this issue. This multicenter study prospectively examined if “rational and antiemotional” behavior
(antiemotionality), characterized by an extreme tendency to suppress emotional behaviors and to rationalize
negative experiences in conflicting interpersonal situations, is associated with the functional prognosis of patients
with RA.
Methods: 532 patients with RA who regularly visited one of eight hospitals/clinics in Japan in 2000 were recruited
for study. All completed a self-administered baseline questionnaire about lifestyle and psychosocial factors including
antiemotionality. Two years after, 460 (mean age, 56.1 years; 54 men and 406 women) of 471 patients who
continued to visit the clinics agreed to take the follow-up questionnaire. The functional status of the patients was
evaluated by rheumatologists based on the ACR classification system.
Results: A multiple logistic regression model that included baseline demographic, disease activity/severity-related,
therapeutic, and socioeconomic factors as covariates found a tendency toward higher antiemotionality to be
related to poorer functional status at follow-up. This relationship was not explained by lifestyle factors.
Conclusions: Antiemotionality may be a prognostic factor for the functional status of patients with RA. This finding
sheds light on a seemingly forgotten issue in the care of patients with RA.
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Rheumatoid arthritis (RA) is an autoimmune disease
characterized by chronic systemic inflammation that
mainly affects joints, which causes a loss of physical func-
tioning. It can lead to severe systemic dysfunction and a
premature death [1]. Physicians and patients agree that
psychosocial stress (stress) in daily life can affect the in-
flammatory and functional status of patients with RA, and* Correspondence: jun@artsci.kyushu-u.ac.jp
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unless otherwise stated.some studies have supported this notion [2-4]. Recent
advancement in psychoneuroimmunology has helped
clarify the mechanisms by which stress affects the disease
through interaction between the endocrine, nervous, and
immune systems [5-7].
Stress, individual internal experience, can be affected
not only by external stressors, but also by interaction
between stressors and individual emotional, cognitive,
and behavioral responses to them [4]. When a person
responds to stressors with a pattern that is repeated on a
frequent basis, such a response pattern can be under-
stood within the context of personality. It is difficult forl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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sible to alter the properties of personality and response
style to stressors, and in turn to modify the effects of
stressors to the RA disease status. For centuries, clini-
cians have been impressed by the role of psychosocial
factors on RA, and in the 1950s and 1960s, RA came to
be viewed as one of the classical psychosomatic diseases
[8,9]. Particular personality factors that possibly relate to
the onset and course of RA have received considerable
attention [10], and a personality characterized by an
inability to express aggressive feelings, e.g., “contained
hostility” [11] was the one on which many researchers
agreed [12]. The nature of these earlier studies included a
cross-sectional design, and they were repeatedly criticized,
with reviewers concurring on the necessity for prospective
studies that allow better causal interpretations [5,9,13,14].
A “neurotic” personality (anxious and depressed), another
hypothesis drawn from some earlier cross-sectional stud-
ies that used the Minnesota Multiphasic Personality
Inventory, was later denied by longitudinal studies [15,16]
and re-interpreted as a result rather than a cause of this
chronic disease [17]. To the authors’ knowledge, however,
even to date few prospective studies have reported on the
classical issue of the repression of negative, especially
aggressive, emotions as a personality factor associated
with the onset/course of RA.
Grossarth-Maticek and colleagues hypothesized that
the “rationality and antiemotionality” or “type 5” behavior
is a risk factor for the onset of chronic diseases including
cancer and RA [18-20]. The rational-antiemotional behav-
ior (antiemotionality) is characterized by an extreme ten-
dency to suppress emotional behaviors and to rationalize
negative experiences in conflicting interpersonal situa-
tions. Thus, this behavioral pattern largely fits the concept
of the repression of negative emotions, whereas it clearly
differs from the concept of neurotic personality. It was
found, in a cohort study begun in the 1970s, that a high
proportion of persons with a highly typical antiemotional-
ity later developed RA [20]. Moreover, it was shown that
“Autonomy Training”, a psychotherapeutic intervention
method, could alter such a tendency in the direction of
healthier behaviors, leading to better physical outcomes
[21-23]. A recent study showed that antiemotionality may
also be a prognostic factor for lung cancer patients [24].
The present multicenter cohort study examined if antie-
motionality is associated with a poorer prognosis for the
functional status of patients with RA.
Methods
Subjects
The baseline data for the present study was taken from a
multi-center cohort survey of Japanese patients with RA
carried out in 2000. It was part of a study supported by
the Ministry of Health and Welfare, Japan entitled“Assessment and improvement of the system for inter-
disciplinary medical services for RA (AISIMS)” [25].
Rheumatologists, one working at each of the 12 hospitals/
clinics that participated in the program, invited patients
with RA who regularly visited their hospitals/clinics to
cooperate with the AISIMS cohort study. Patient eligibility
included age between 20 and 79 years, the ability to an-
swer a self-administered questionnaire without assistance,
and functional status of class 3 or better by the criteria of
the American College of Rheumatology (ACR) (see below)
[26]. The baseline survey consisted of a self-administered
questionnaire for the patients and a clinical data sheet
completed by their rheumatologist. The questionnaire
inquired about a variety of factors including activity
of daily living, quality of life, and lifestyle (smoking,
alcohol-drinking, physical exercise, sleep, diet, etc.)
and about psychosocial factors (major life events, stress/
personality, etc.). The items for the clinical data sheet
included factors relevant to the disease status of RA,
such as progression of arthritis, functional status, extra-
articular complications, and factors associated with med-
ical treatment.
In 2002, two years after the baseline survey, eight of
the 12 hospitals/clinics participated in the follow-up sur-
vey, with the 23 rheumatologists who were working at
these eight hospitals/clinics completing the same clinical
data sheet as that used for the baseline survey and hand-
ing each patient participant a follow-up questionnaire
with items selected from the baseline questionnaire. The
follow-up survey was completed before 2003, when the
first biologic agent (infliximab) became available in Japan
for the treatment of patients with RA [27], because an
expected high effectiveness of the agents [1] could over-
shadow the associations of lifestyle and psychosocial
factors with the prognosis of patients with RA and lower
the statistical power to detect them. The patients who
agreed to cooperate with the follow-up survey sent their
completed questionnaires to a central office located at the
Department of Preventive Medicine, Kyushu University
Graduate School of Medical Sciences. The rheumatol-
ogists who evaluated the patients’ clinical status were
blinded from the patients’ answers for both the base-
line and follow-up questionnaires.
Measurements
The rheumatologists assessed their patients’ functional
status based on the criteria for classification of func-
tional status in RA defined by ACR (ACR class), which
classifies patients with RA into one of four classes as fol-
lows: Class I: completely able to perform usual activities
of daily living (self-care, vocational, and avocational);
Class II: able to perform usual self-care and vocational
activities, but limited in avocational activities; Class III:
able to perform usual self-care activities, but limited in
Table 1 Demographic and baseline clinical characteristics
of patients with rheumatoid arthritis (N = 460)
Characteristics N (%)
Age, yrs, mean (SD) 56.1 (9.6)
Female 406 (88.3)
Education completed
Junior high school 114 (24.8)
High school 251 (54.6)
Junior college or higher 95 (20.6)










Afflicted joint* count (0–49), mean (SD) 10.0 (8.8)




C-reactive protein, mg/dl, mean (SD) 1.63 (2.11)
Medical treatments†
Methotrexate use 194 (42.2)
Corticosteroids use 205 (44.6)
Other DMARDs use 246 (53.5)
SD: standard deviation, ACR: American College of Rheumatology, DMARDs:
disease modifying anti-rheumatic drugs. *See text for explanation. †Based on a
yes/no choice. Values are N (%) unless otherwise stated.
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ited in ability to perform usual self-care, vocational, and
avocational activities [26]. They also assessed the status
of joint damage based on the classification by Steinbrocker
et al. (joint stage: Stage I, Early; Stage II, Moderate; Stage
III, Severe; and Stage IV, Terminal) [28]; specified afflicted
joints defined as those with either tenderness, swelling,
or deformity; and listed extra-articular complications
using the following options: cervical myelopathy, cardiac/
pericardial manifestations, pulmonary/pleural manifesta-
tions, ocular manifestations, peripheral nervous manifes-
tations, hematological manifestations, and others.
Personality factors including antiemotionality were
assessed using the “Stress Inventory (SI)” [29,30]. SI is a
self-administered questionnaire consisting of 45 items
that was developed to assess response styles to stressors
principally related to an interpersonal relationship or to
chronic stress posed by the response style, that are rele-
vant to chronic diseases [31-33]. Of the 12 scales consti-
tuting the SI, the “rationalizing conflicts/frustrations
(RCF)” scale measures an extreme tendency to rational-
ize one’s interpersonal situations accompanied by con-
flicts or frustrations, and was developed to represent
antiemotionality. This scale consists of five questions, such
as “do you under all circumstances try to control your rea-
soning and avoid, as much as possible, being emotional?”
(Cronbach α = 0.78). The answers receive a 1 to 6 rating,
where 1 and 6 respectively correspond to “yes” and “no”
or to “almost always” and “rarely”, and the scores are aver-
aged for the scale score, thus a higher score represents a
higher tendency.
Analysis
The ACR class at follow-up was dichotomized (poorer
function, Class 3 or 4 vs. better function, Class 1 or 2)
and used as the outcome variable representing the func-
tional prognosis of the patients with RA. The association
between antiemotionality and the functional prognosis
was examined using a multiple logistic regression model
that included the dichotomized ACR class at follow-up
as a dependent variable, the RCF score (1–6) as an inde-
pendent variable, and baseline ACR class (Class I, II, III,
IV = 1, 2, 3, 4, respectively) as a covariable. The associ-
ation was then examined after controlling for known or
potential confounding factors including sex; age; factors
relevant to disease progression or activity: joint stage
(Stage I, II, III, IV = 1, 2, 3, 4, respectively), afflicted
joints count (1–45), number of extra-articular complica-
tions (0–5), C-reactive protein with log-transformation;
medical treatments: methotrexate, corticosteroids, other
DMARDs (yes = 1, no = 0); and socioeconomic status: edu-
cation level (junior high school = 1, high school = 2, junior
college = 3, college = 4). Finally, potential intervening ef-
fects of lifestyle factors were examined by adding thefollowing variables into this multivariate model: smok-
ing (current smoker = 1, non-/ex-smoker = 0), alcohol
drinking (current drinker = 1, non-/ex-drinker = 2), ex-
ercise habit (none = 0, 1–3 times/w = 1, 4+ times/w = 2),
sleep habit (7–8 hrs/night =1, others = 0), green-yellow vege-
table intake (not eat = 1, once/w = 2, 2-4/w = 3, 5-6/w = 4,
every day = 5) and fruit intake (same as green-yellow
vegetables).
Results
At the time of the follow-up survey, seven of the 532 pa-
tients had died, 13 were visiting another hospital/clinic,
and 33 had quit visiting for unknown reasons. The doc-
tors in charge handed the follow-up questionnaire to the
479 patients who continued visiting, and 460 of them sent
a completed questionnaire to the central office. Table 1
summarizes the demographics and baseline characteristics
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the patients who were lost to follow-up (visiting another
hospital/clinic or having quit visiting for unknown rea-
sons, N = 46) were not statistically different from those of
the subjects included in the analysis (see Additional file 1:
Table A1). Table 2 shows the baseline characteristics of
the subjects according to the degree of antiemotionality.
Greater antiemotionality was associated with female sex,
older age, and greater number of afflicted joints.
The ACR class distribution at the follow-up was as fol-
lows: Class 1, 65 (14.1%); Class 2, 327 (71.0%); Class 3,
59 (12.8%); and Class 4, 9 (2.0%); thus, global functional
status had improved for 56 (12.2%), was unchanged for
328 (71.3%), and had deteriorated for 76 (16.5%) over
the two-year study period. Figure 1 shows the change in
ACR class over the period according to the RCF score.
Table 3 shows the results of the multiple logistic
regression analysis done to examine the association
between antiemotionality and the functional prognosis.
Greater antiemotionality (a higher RCF score) was asso-
ciated with a poorer ACR class two-years after the base-
line survey in the model that only included baseline
ACR class as a covariate (Model 1). When multiple factors
relevant to demographics, disease activity/progression,
treatments, and socioeconomic status were additionally
adjusted, the association between antiemotionality and theTable 2 Association at baseline between antiemotionality
and the demographic and clinical characteristics of
patients with rheumatoid arthritis (N = 460)







Female 82.8 86.6 95.0 .001
Age, yrs, mean (SD) 54.9 (10.0) 56.0 (10.3) 57.4 (8.5) .033
Education, college or higher 22.8 20.4 19.0 .85
Duration, yrs, mean (SD) 11.6 (9.8) 9.9 (8.5) 12.7 (10.0) .41
ACR class > = 3 13.8 11.5 15.2 .75
Joint stage‡ > = 3 65.5 66.2 68.4 .45
Afflicted joints‡
count, mean (SD)
9.9 (9.4) 9.0 (7.8) 11.1 (9.0) .028
No. extra-articular
complications‡ > = 1
23.5 23.0 24.7 .49
CRP, mg/dl, mean (SD) 1.49 (1.87) 1.76 (2.50) 1.63 (1.90) .12
Methotrexate use 38.6 43.4 44.3 .48
Corticosteroids use 44.8 42.0 46.8 .86
Other DMARDs use 54.5 54.1 51.9 .95
RCF: rationalizing conflicts/frustrations. ACR: American College of
Rheumatology, CRP: C-reactive protein, DMARDs: disease modifying
anti-rheumatic drugs. *The score of the rationalizing conflicts/frustrations scale
of the Stress Inventory; the degrees of antiemotionality, “low”, “moderate”, and
“high”, were based on the tertiles of the RCF score, 3.8 and 4.6. †Based on
Spearman’s rank correlation. ‡See text for explanation. Values are % unless
otherwise stated.
Figure 1 Changes in the functional status of patients with
rheumatoid arthritis according to the degree of antiemotionality.
RCF score: the score of the rationalizing conflicts/frustrations scale of
the Stress Inventory; “low”, “moderate” and “high” represent the RCF
score of < 3.8, 3.8 to < 4.6, and 4.6+, respectively. ACR: American
College of Rheumatology. BL: at the time of the baseline survey, 2Y:
two years after the baseline survey.functional prognosis did not materially change (Model 2).
A one point increment in the baseline RCF score was
associated with a nearly 50% higher chance of having a
poorer functional status rather than a better status at the
follow-up. The possible intervening effect of lifestyle fac-
tors, including smoking, alcohol consumption, exercise,
sleep hours, green/yellow vegetable intake, and fruit in-
take, was then examined. Additional adjustment for these
factors, however, did not appreciably change the associ-
ation between antiemotionality and the functional progno-
sis (OR = 1.60, 95% CI = 1.16-2.22, P = 0.005).
Discussion
This Japanese, multicenter, cohort study supports the
hypothesis that a strong tendency toward antiemotional-
ity, previously reported as a risk factor for the onset of
RA [20], is also associated with the functional prognosis
of patients with RA. This is, to the authors’ knowledge,
the first prospective study that supports the classical notion
that a personality characterized by emotional suppression
Table 3 Multiple logistic regression analysis of the association between antiemotionality at baseline and the functional
prognosis (ACR class at follow-up) of patients with rheumatoid arthritis
Baseline variables Model 1 Model 2
OR (95% CI) P OR (95% CI) P
Antiemotionality (RCF score*) 1.40 (1.05-1.87) .023 1.47 (1.07-2.00) .016
ACR class 10.52 (5.87-18.9) <.001 6.13 (3.17-11.8) <.001
Female sex 1.92 (0.53-6.98) .32
Age 1.00 (0.96-1.04) .99
Joint stage* 1.20 (0.80-1.78) .38
Afflicted joints* count 1.03 (1.00-1.07) .06
No. extra-articular complications* 1.40 (0.96-2.02) .08
Log. C-reactive protein 1.30 (0.99-1.71) .06
Methotrexate use 1.39 (0.67-2.88) .38
Corticosteroids use 0.43 (0.20-0.94) .034
Other DMARDs use 1.12 (0.54-2.32) .76
Education level 0.80 (0.52-1.23) .30
ACR: American College of Rheumatology. OR: odds ratio of a poorer function (Class 3 or 4) vs. a better function (Class 1 or 2) at follow-up. CI: confidence interval.
RCF: rationalizing conflicts/frustrations. *See text for explanation.
Nagano et al. BioPsychoSocial Medicine 2014, 8:8 Page 5 of 7
http://www.bpsmedicine.com/content/8/1/8has a particular connection with the course of RA. The
RCF score was differently correlated with specific aspects of
negative emotionality in a study of its psychometrical valid-
ity [30]. Its positive and negative correlations respectively
with “anger-in” and “anger-out”, concepts by Spielberger
[34], support earlier cross-sectional findings of the inability
to express aggressive feelings associated with a poorer
course of this disease [10-12]. That the RCF score was not
correlated with trait-anxiety or depression is consistent with
the null association between “neurotic” personality and the
course of RA in previous longitudinal studies [15,16].
Although this study was of a prospective design, the
observed association will need to be further scrutinized
for possible confounding effects. Factors representing
disease activity, chronic symptoms and functional dis-
ability, and medical treatments that potentially affect the
central nervous system may have affected the baseline
RCF scores. Socioeconomic status, known as a possible
prognostic factor for patients with RA [35], may also be
correlated with RCF. However, the prospective association
of antiemotionality with functional disability at follow-up
was independent of all of these baseline factors.
Except for smoking’s exacerbating effect, no lifestyle
factor has been established as affecting the disease
course of RA [1,36]. However, lifestyle factors should be
considered major pathways that potentially link psycho-
social variables and physical outcomes. Various factors
considered to be generally favorable or unfavorable for
health, such as smoking, alcohol-drinking, physical exercise,
sleep, and diet were examined for their potential interven-
ing effects, but they did not explain the antiemotionality-
prognosis association.Another pathway to be considered is the psycho-
physiological system. The hypothalamus is the center of
the autonomic nervous system (ANS) and of the
hypothalamus-pituitary-adrenal (HPA) axis, and it has
been progressively elucidated that the ANS, HPA axis,
and immune system are closely connected and that they
interact with each other [5-7]. When the cerebral cortex,
the center of reason, chronically and overly interferes
with the limbic system, which is responsible for emo-
tional responses, this may affect the function of the
hypothalamus, which is closely connected to the limbic
system, and in turn the function of the immune system.
Such behaviors by which a person attempts to maintain
imperturbability or to understand another person when
confronting a frustrating interpersonal situation will
be, when appropriately employed, harmless or rather
preferable. However, when such behaviors are extremely
employed, i.e., negative emotions are always rationalized
and their expression is blocked, the emotions that lost
outlet may damage the functioning of biological homeo-
stasis. Ishii et al. found that patients with RA who were
easily moved to tears as a response to psychological stress
showed a better response to treatment and a better gen-
eral prognosis than those who did not show such emo-
tional responses [37].
This study has several limitations. First, no biomarkers,
such as neuroendocrinological or immunological markers
were measured that can be related to the above discussion
of the psycho-physiological pathway. Second, although the
outcome measure used, ACR class, is convenient for
assessment and represents the overall functional status of
patients with RA, its sensitivity to detect temporal changes
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pletely on the subjective evaluation of the rheumatologist,
while other commonly used scoring systems, such as the
ACR core set and the Disease Activity Score, integrate ob-
jective markers and subjective evaluations by both doctors
and patients [39,40]. Third, the present data only included a
small number of male patients, and thus could not address
possible sex-related difference in the antiemotionality-
prognosis association. Nevertheless, this study adds new
findings to the currently insufficient prospective data con-
cerning specific personalities and relevant properties that
contribute to the progression of RA. The present results
were based on a relatively large sample that was collected at
multiple hospitals across Japan and can be generalized to
Japanese patients with RA.
Conclusions
Antiemotionality, a personality trait characterized by
strong suppression of becoming emotional and by overly
appealing to reason in stressful interpersonal situations,
is associated with a poorer functional prognosis for pa-
tients with RA. This finding sheds light on a seemingly
forgotten issue in the care of patients with RA.
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